LORNOXICAM DRUG PROFILE PDF

  • No Comments

Lornoxicam is a non-steroidal anti-inflammatory drug of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. It is available in oral and. Lornoxicam is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic (pain relieving), anti-inflammatory. Lornoxicam is a nonsteroidal anti-inflammatory drug with analgesic properties From: Profiles of Drug Substances, Excipients and Related Methodology,

Author: Magis Tojanos
Country: Argentina
Language: English (Spanish)
Genre: Spiritual
Published (Last): 13 March 2007
Pages: 345
PDF File Size: 3.28 Mb
ePub File Size: 2.42 Mb
ISBN: 549-7-18725-447-8
Downloads: 53475
Price: Free* [*Free Regsitration Required]
Uploader: Shaktir

Choline magnesium trisalicylate The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Lornoxicam.

Latanoprost The therapeutic efficacy of Latanoprost can be decreased when used in combination with Lornoxicam. Canrenone The risk or severity of hyperkalemia profiel be increased when Lornoxicam is combined with Canrenone.

Galantamine Lornoxicam may decrease the excretion rate of Galantamine which could result in a higher serum level. Flunoxaprofen The risk or severity of adverse effects can be increased when Lornoxicam is combined with Flunoxaprofen. Etodolac The risk or severity of adverse effects can be increased when Etodolac is combined with Lornoxicam.

Lornoxicam information from DrugsUpdate

Hydracarbazine The risk or severity of hypertension can be increased when Lornoxicam is combined with Hydracarbazine. Mecamylamine The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Lornoxicam.

Lornoxicam chlortenoxicam is a new nonsteroidal anti-inflammatory drug NSAID of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Lornoxicam.

Emtricitabine Lornoxicam may decrease the excretion rate of Emtricitabine which could result in a higher serum level. Lorpiprazole Lornoxicam may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.

  GUIA PRINCE OF PERSIA LAS DOS CORONAS PS2 PDF

Astaxanthin The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Astaxanthin. Canakinumab The metabolism of Lornoxicam can be increased when combined with Canakinumab. Icosapent The risk or severity of adverse effects can be lornoxlcam when Lornoxicam is combined with Icosapent. Cidofovir Lornoxicam may decrease the excretion rate of Lorhoxicam which rrug result in a higher serum level.

Azilsartan medoxomil The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Lornoxicam.

Cimicifuga racemosa The metabolism of Lornoxicam can be decreased when combined with Cimicifuga racemosa. Indoramin The therapeutic efficacy of Indoramin can be decreased when used in combination with Lornoxicam. Dextran Lornoxicam may decrease the excretion rate of Dextran which could result in a higher serum level.

Lornoxicam drug information | DrugsUpdate India

Etanercept The metabolism of Lornoxicam can be increased when combined with Etanercept. See Available Brands of Lornoxicam in India P – Contraindicated in pregnancy L – Contraindicated in lactation Lornoxicam chlortenoxicam is a non-steroidal anti-inflammatory drug NSAID of the oxicam class with analgesic, anti-inflammatory and antipyretic properties.

Dosage Oral Pain relief Adult: Retrieved from ” peofile Dihydroergotamine The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Lornoxicam. Atenolol Lornoxicam may decrease the antihypertensive lonroxicam of Atenolol. Chlorphentermine The risk or severity pornoxicam hypertension can be increased when Chlorphentermine is combined with Lornoxicam. Abediterol The risk or severity of hypertension can be increased when Lornoxicam is combined with Abediterol.

Allopurinol Lornoxicam may decrease the excretion rate of Allopurinol which could result in a higher serum level. Caroverine The risk or severity of hyperkalemia can be increased when Lornoxicam is combined with Caroverine.

  CERBERUS P 6331-62 PDF

There was a problem providing the content you requested

Lornoxicam INNor chlortenoxicam ; trade name Xefoamong others is a nonsteroidal anti-inflammatory drug NSAID of the oxicam class with analgesic pain relievinganti-inflammatory and antipyretic fever reducing properties. Lurasidone The risk or severity of hypertension can be increased when Lornoxicam is combined with Lurasidone.

Difloxacin Lornoxicam may increase the neuroexcitatory activities of Difloxacin.

Melagatran The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Melagatran.

Etidronic acid The risk or severity of gastrointestinal bleeding can be increased when Lornoxicam is combined with Etidronic profilr. Esmirtazapine The risk or severity of hypertension can be increased when Esmirtazapine is combined with Lornoxicam. Meprednisone The risk or severity of gastrointestinal frug can be increased when Meprednisone is combined with Lornoxicam. Amitriptyline Lornoxicam may decrease the excretion rate of Amitriptyline which could result in a higher serum level.

Gadoteric acid Lornoxicam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level. Frovatriptan The risk or severity of hypertension can be increased when Frovatriptan is combined with Lornoxicam. Amlodipine The therapeutic efficacy of Amlodipine can be decreased when used in combination with Lornoxicam. Adrafinil The risk or severity of hypertension can be increased when Lornoxicam is combined lrnoxicam Adrafinil.